Veracyte Inc VCYT Stock Quotes and Insider News

Insider Chart Past 6 Months

Technical Chart

Filings by transaction date

Jan 20, 2021 (filed on Jan 21, 2021)

Insider Name:

Ho Mark

Ownership Type:

Direct Ownership

Securities:

Stock Option (right to buy)

Nature of Transaction:

M - Exercise or conversion exempt under rule 16b-3

# or value acquired/disposed of:

-7,500

Price:

--
Jan 20, 2021 (filed on Jan 21, 2021)

Insider Name:

Ho Mark

Ownership Type:

Direct Ownership

Securities:

Stock Option (right to buy)

Nature of Transaction:

M - Exercise or conversion exempt under rule 16b-3

# or value acquired/disposed of:

-45,000

Price:

--
Jan 20, 2021 (filed on Jan 21, 2021)

Insider Name:

Ho Mark

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

M - Exercise or conversion exempt under rule 16b-3

# or value acquired/disposed of:

7,500

Price:

$6.45
Jan 20, 2021 (filed on Jan 21, 2021)

Insider Name:

Ho Mark

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

M - Exercise or conversion exempt under rule 16b-3

# or value acquired/disposed of:

45,000

Price:

$4.94
Jan 13, 2021 (filed on Jan 15, 2021)

Insider Name:

Anderson Bonnie H

Ownership Type:

Direct Ownership

Securities:

Stock Option (right to buy)

Nature of Transaction:

M - Exercise or conversion exempt under rule 16b-3

# or value acquired/disposed of:

-18,541

Price:

--
Jan 13, 2021 (filed on Jan 15, 2021)

Insider Name:

Anderson Bonnie H

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

S - Open market or private sale

# or value acquired/disposed of:

-12,177

Price:

$51.26
Jan 13, 2021 (filed on Jan 15, 2021)

Insider Name:

Anderson Bonnie H

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

S - Open market or private sale

# or value acquired/disposed of:

-6,364

Price:

$50.64
Jan 13, 2021 (filed on Jan 15, 2021)

Insider Name:

Anderson Bonnie H

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

M - Exercise or conversion exempt under rule 16b-3

# or value acquired/disposed of:

18,541

Price:

$5.61
Jan 12, 2021 (filed on Jan 13, 2021)

Insider Name:

Anderson Bonnie H

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

S - Open market or private sale

# or value acquired/disposed of:

-400

Price:

$51.20
Jan 12, 2021 (filed on Jan 13, 2021)

Insider Name:

Anderson Bonnie H

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

S - Open market or private sale

# or value acquired/disposed of:

-15,568

Price:

$50.29

Filings by filing date

Jan 20, 2021 (filed on Jan 21, 2021)

Insider Name:

Ho Mark

Ownership Type:

Direct Ownership

Securities:

Stock Option (right to buy)

Nature of Transaction:

M - Exercise or conversion exempt under rule 16b-3

# or value acquired/disposed of:

-7,500

Price:

--
Jan 20, 2021 (filed on Jan 21, 2021)

Insider Name:

Ho Mark

Ownership Type:

Direct Ownership

Securities:

Stock Option (right to buy)

Nature of Transaction:

M - Exercise or conversion exempt under rule 16b-3

# or value acquired/disposed of:

-45,000

Price:

--
Jan 20, 2021 (filed on Jan 21, 2021)

Insider Name:

Ho Mark

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

M - Exercise or conversion exempt under rule 16b-3

# or value acquired/disposed of:

7,500

Price:

$6.45
Jan 20, 2021 (filed on Jan 21, 2021)

Insider Name:

Ho Mark

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

M - Exercise or conversion exempt under rule 16b-3

# or value acquired/disposed of:

45,000

Price:

$4.94
Jan 13, 2021 (filed on Jan 15, 2021)

Insider Name:

Anderson Bonnie H

Ownership Type:

Direct Ownership

Securities:

Stock Option (right to buy)

Nature of Transaction:

M - Exercise or conversion exempt under rule 16b-3

# or value acquired/disposed of:

-18,541

Price:

--
Jan 13, 2021 (filed on Jan 15, 2021)

Insider Name:

Anderson Bonnie H

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

S - Open market or private sale

# or value acquired/disposed of:

-12,177

Price:

$51.26
Jan 13, 2021 (filed on Jan 15, 2021)

Insider Name:

Anderson Bonnie H

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

S - Open market or private sale

# or value acquired/disposed of:

-6,364

Price:

$50.64
Jan 13, 2021 (filed on Jan 15, 2021)

Insider Name:

Anderson Bonnie H

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

M - Exercise or conversion exempt under rule 16b-3

# or value acquired/disposed of:

18,541

Price:

$5.61
Jan 12, 2021 (filed on Jan 13, 2021)

Insider Name:

Anderson Bonnie H

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

S - Open market or private sale

# or value acquired/disposed of:

-400

Price:

$51.20
Jan 12, 2021 (filed on Jan 13, 2021)

Insider Name:

Anderson Bonnie H

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

S - Open market or private sale

# or value acquired/disposed of:

-15,568

Price:

$50.29

News

Biz Brief

Sector: Healthcare	Industry: Biotechnology & Medical Research

See Regulatory Filings on SEC

Company Contact

Address:	6000 Shoreline Ct Ste 300 SOUTH SAN FRANCISCO CA 94080-7606
Tel:	1-650-3804413
Website:	https://www.veracyte.com
IR:	See website

Key People

Bonnie H. Anderson Chairman of the Board, Chief Executive Officer	Keith S. Kennedy Chief Financial Officer, Chief Operating Officer	James H. Erlinger Executive Vice President, General Counsel, Secretary
Giulia C. Kennedy Chief Scientific Officer, Chief Medical Officer	Morten Frost General Manager - Pulmonology	John Walter Hanna General Manager - Endocrinology, Breast Cancer and lymphoma

Business Overview

Veracyte, Inc. is a genomic diagnostics company. The Company, through its scientific platform, which utilizes ribonucleic acid (RNA), whole-transcriptome sequencing combined with machine learning, produces genomic tests. It provides various genomic tests, including Afirma Genomic Sequencing Classifier (GSC), Percepta Bronchial Genomic Classifier, Envisia Genomic Classifier and Afirma Xpression Atlas. It provides GSC tests for thyroid cancer. It provides Percepta Bronchial Genomic Classifier tests for lung cancer. It provides Envisia Genomic Classifier tests for idiopathic pulmonary fibrosis (IPF). Its Afirma Xpression Atlas provides information on gene alterations associated with thyroid cancer, enabling physicians to tailor surgical and treatment decisions at time of diagnosis.

Financial Overview

For the nine months ended 30 September 2020,Veracyte Inc revenues decreased 8% to $82.9M. Net lossincreased from $5.1M to $26.9M. Revenues reflect a decreasein demand for the Company's products and services due tounfavorable market conditions. Higher net loss reflectsSelling and marketing increase of 20% to $23.2M (expense),Intangible asset amortization increase from $800K to $3.8M(expense).

Employees:	354 as of Dec 31, 2019

Reporting Currency:	U.S. Dollars
Enterprise value:	$2,854M as of Sep 30, 2020
Annual revenue (TTM):	$112.68M as of Sep 30, 2020
EBITDA (TTM):	-$28.31M as of Sep 30, 2020
Net annual income (TTM):	-$34.32M as of Sep 30, 2020
Free cash flow (TTM):	-$13.23M as of Sep 30, 2020
Net Debt Last Fiscal Year:	N/A
Shares outstanding:	57,897,321 as of Oct 28, 2020
TTM: Trailing Twelve Months EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization

INK Ultra Money Free

INK Ultra Money Videos

Veracyte Inc (OQ:VCYT)